Loading organizations...
Loading organizations...
Cancer vaccines and T cell therapies for cold tumors using AI.
ErVimmune has raised $19.9M across 1 funding round.
ErVimmune has raised $19.9M in total across 1 funding round.
ErVimmune has raised $19.9M in total across 1 funding round.
ErVimmune's investors include Isabelle de Cremoux, Michael Shleifer.
ErVimmune has raised $19.9M across 1 funding round. Most recently, it raised $19.9M Series A in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 21, 2026 | $19.9M Series A | Isabelle de Cremoux, Michael Shleifer |